Tetrahydroxystilbene glucoside protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity

European Journal of Pharmacology

Volumn 660, Issue 2-3, 2011, Pages 283-290

  Sun, Fang Ling ^a   Zhang, Lan ^a   Zhang, Ru Yi ^a   Li, Lin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Mitochondrion; MPP+; Oxidative stress; Parkinson's disease; Tetrahydroxystilbene glucoside

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2,3,5,4' TETRAHYDROXYSTILBENE 2 O BETA DEXTRO GLUCOSIDE; CASPASE 3; DICHLORODIHYDROFLUORESCEIN DIACETATE; LACTATE DEHYDROGENASE; PLANT MEDICINAL PRODUCT; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRAIN SH SY5Y; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROBLASTOMA CELL; POLYGONUM; POLYGONUM MULTIFLORUM; PRIORITY JOURNAL; UPREGULATION;

1-METHYL-4-PHENYLPYRIDINIUM; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; CYTOPROTECTION; GENE EXPRESSION REGULATION; GLUCOSIDES; HUMANS; MITOCHONDRIA; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 79956097531     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.03.046     Document Type: Article

References (43)

1. + and MPTP induced oxygen radical formation with mitochondrial enzymes. Free Radic. Biol. Med. 15, 181-186.
2. Bates, T.E., Heales, S.J., Davies, S.E., Boakye, P., Clark, J.B., 1994. Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: evidence for a primary involvement of energy depletion. J. Neurochem. 63, 640-648. (Pubitemid 24233700)
3. Braak, H., Rub, U., Gai, W.P., Del Tredici, K., 2003. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural Transm. 110, 517-5360.
4. Brumatti, G., Sheridan, C., Martin, S.J., 2008. Expression and purification of recombinant annexin V for the detection of membrane alterations on apoptotic cells. Methods 44, 235-240. (Pubitemid 351296441)
5. + affects microtubule dynamics by acting as a destabilising factor. FEBS Lett. 579, 4781-4786.
6. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta. 1453, 49-62.
7. Cory, S., Adams, J.M., 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2, 647-656.
8. Dauer, W., Przedborski, S., 2003. Parkinson's disease: mechanisms and models. Neuron 39, 889-909. (Pubitemid 37130207)
9. +. Neurosci. Lett. 433, 219-224.
10. +) cytotoxicity. Biochem. Biophys. Res. Commun. 137, 303-309.
11. Drechsel, D.A., Patel, M., 2008. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. Free Radic. Biol. Med. 44, 1873-1886.
12. Ghosh, A., Chandran, K., Kalivendi, S.V., Joseph, J., Antholine, W.E., Hillard, C.J., Kanthasamy, A., Kanthasamy, A., Kalyanaraman, B., 2010. Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radic. Biol. Med. 49, 1674-1684.
13. Gómez-Santos, C., Ferrer, I., Reiriz, J., Vinals, F., Barrachina, M., Ambrosio, S., 2002. MPP+ increases a-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 935, 32-39. (Pubitemid 34327842)
14. Hartmann, A., Hunot, S., Michel, P.P., Muriel, M.P., Vyas, S., Faucheux, B.A., Mouatt-Prigent, A., Turmel, H., Srinivasan, A., Ruberg, M., Evan, G.I., Agid, Y., Hirsch, E.C., 2000. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. PNAS 97, 2875-2880. (Pubitemid 30159265)
15. Höglinger, G.U., Carrard, G., Michel, P.P., Medja, F., Lombès, A., Ruberg, M., Friguet, B., Hirsch, E.C., 2003. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J. Neurochem. 86, 1297-1307. (Pubitemid 37022204)
16. Korsmeyer, S.J., Shutter, J.R., Veis, D.J., Merry, D.E., Oltvai, Z.N., 1993. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4, 327-332.
17. + increases the vulnerability to oxidative stress rather than directly mediating oxidative damage in human neuroblastoma cells. Exp. Neurol. 165, 164-171.
18. +-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway. Eur. J. Cell Biol. 87, 389-397.
19. Lesage, S., Brice, A., 2009. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 18, 48-50.
20. Liu, Q.L., Xiao, J.H., Ma, R., Ban, Y., Wang, J.L., 2007. Effect of 2,3,5,4'-tetrahydroxystilbene- 2-O-beta-D-glucoside on lipoprotein oxidation and proliferation of coronary arterial smooth cells. J. Asian Nat. Prod. Res. 9, 689-697.
21. +-induced cytotoxicity in PC12 cells via inhibition of mitochondrial dysfunction and ROS production. Neurochem. Int. 57, 206-215.
22. Lu, J.N., Park, C.S., Lee, S.K., Shin, D.W., Kang, J.H., 2006. Leptin inhibits 1-methyl-4-phenylpyridinium-induced cell death in SH-SY5Y cells. Neurosci. Lett. 407, 240-243.
23. Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Method 65, 55-63. (Pubitemid 14203433)
24. Niles, A.L., Moravec, R.A., Hesselberth, P.E., Scurria, M.A., Daily, W.J., Riss, T.L., 2007. A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. Anal. Biochem. 366, 197-206.
25. + but not 6-OHDA induced cell death in dopaminergic neurons. Neurobiol. Dis. 14, 43-51.
26. Perkins, C.L., Fang, G., Kim, C.N., Bhalla, K.N., 2000. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res. 60, 1645-1653. (Pubitemid 30183437)
27. Poewe, W., 2008. Non-motor symptoms in Parkinson's disease. Eur. J. Neurol. 15, 14-20.
28. Prabhakara, J.P.R., Feist, G., Thomasson, S., Thomasson, A., Schommer, E., Ghribi, O., 2008. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and a-synuclein in human neuroblastoma SH-SY5Y cells. J. Neurochem. 107, 1722-1729.
29. Satoh, T., Enokido, Y., Aoshima, H., Uchiyama, Y., 1997. Changes in mitochondrial membrane potential during oxidative stress-induced apoptosis in PC12 cells. Neurosci. Res. 50, 413-420.
30. Schapira, A.H., 2008. Mitochondrial dysfunction in neurodegenerative disease. Neurochem. Res. 12, 2502-2509.
31. Smeyne, R.J., Jackson-Lewis, V., 2005. The MPTP model of Parkinson's disease. Brain Res. Mol. Brain Res. 134, 57-66.
32. Waffo-Teguo, P., Fauconneau, B., Deffieux, G., Huguet, F., Vercauteren, J., Mérillon, J.M., 1998. Isolation, identification, and antioxidant activity of three stilbene glucosides newly extracted from Vitis vinifera cell cultures. J. Nat. Prod. 5, 655-657.
33. +-induced cytotoxicity. Neurosci. Res. 51, 129-138.
34. +-treated MN9D cells: a mechanism of toxicity study. Neurotoxicology 28, 979-987.
35. Wang, R., Tang, Y., Feng, B., Ye, C., Fang, L., Zhang, L., Li, L., 2007b. Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats. Neuroscience 49, 739-746. (Pubitemid 350130289)
36. Wang, X., Zhao, L., Han, T., Chen, S., Wang, J., 2008. Protective effects of 2,3,5,4′-tetrahydroxystilbene-2-O-beta-d-glucoside, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice. Eur. J. Pharmacol. 578, 339-348.
37. Wang, T., Gu, J., Wu, P.F., Wang, F., Xiong, Z., Yang, Y.J., Wu, W.N., Dong, L.D., Chen, J.G., 2009. Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/ RNS generation. Free Radic. Biol. Med. 47, 229-240.
38. Yan, H.L., Xue, G., Mei, Q., Wang, Y.Z., Ding, F.X., Liu, M.F., Lu, M.H., Tang, Y., Yu, H.Y., Sun, S.H., 2009. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 28, 2719-2732.
39. Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A., Cai, J., 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132. (Pubitemid 27097312)
40. Zhang, L., Xing, Y., Ye, C.F., Ai, H.X., Wei, H.F., Li, L., 2006. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside. Behav. Brain Res. 173, 246-254.
41. Zhang, L., Yu, H., Sun, Y., Lin, X., Chen, B., Tan, C., Cao, G., Wang, Z., 2007. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur. J. Pharmacol. 564, 18-25.
42. Zhang, S.H., Wang, W.Q., Wang, J.L., 2009. Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo. Acta Pharmacol. Sin. 30, 1479-1487.
43. Zhao, D.L., Zou, L.B., Lin, S., Shi, J.G., Zhu, H.B., 2008. 6,7-di-O-glucopyranosyl-esculetin protects SH-SY5Y cells from dopamine-induced cytotoxicity. Eur. J. Pharmacol. 580, 329-338.